WebPassage Bio earnings history information, presented by NextEarningsDate.com. Home; Calendar; History; Surprises This PASG earnings history page last updated 3/30/2024. … WebPASG will report Q3 2024 earnings on 11/15/2024 EPS Surprise Estimate Actual Q3 2024 Q4 2024 Q1 2024 Q2 2024 -1 -0.8 -0.6 Analyst Ratings Upgrades/Downgrades View All …
Passage Bio Inc (PASG) Stock Price & News - Google Finance
Web12 Apr 2024 · Citigroup ( NYSE:C – Get Rating) last announced its quarterly earnings data on Friday, January 13th. The company reported $1.10 earnings per share for the quarter, missing the consensus estimate of $1.18 by ($0.08). The company had revenue of $18.01 billion during the quarter, compared to the consensus estimate of $17.91 billion. WebParis Saint-Germain have a total of 59 players in their home squad. Paris Saint-Germain play in the Ligue 1, the premier division of football in France.Paris Saint-Germain total wage bill … al25490
Chitavi (Chloe) Maulloo, Ph.D. - LinkedIn
Web6 Mar 2024 · Passage Bio, Inc. (PASG) SEC Filing 10-K Annual Report for the fiscal year ending Saturday, December 31, 2024. Home. SEC Filings. Passage Bio, Inc. (PASG) 10-K … Web31 Mar 2024 · The Passage Bio, Inc. stock price fell by -2.29% on the last day (Friday, 31st Mar 2024) from $0.98 to $0.96. During the last trading day the stock fluctuated 7.37% from a day low at $0.95 to a day high of $1.02. The price has fallen in 7 of the last 10 days and is down by -14.49% for this period. Volume has increased on the last day by 232 ... Web12 Apr 2024 · The main competitors of TransEnterix include Else Nutrition (BABYF), Pro-Dex (PDEX), Black Diamond Therapeutics (BDTX), Viracta Therapeutics (VIRX), Passage Bio (PASG), TCR2 Therapeutics (TCRR), Lucid Diagnostics (LUCD), Gain Therapeutics (GANX), Gamida Cell (GMDA), and Hepion Pharmaceuticals (HEPA). These companies are all part … al-2500